Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 9—September 2024
Research

Medical Costs of Nontuberculous Mycobacterial Pulmonary Disease, South Korea, 2015–2019

Shihwan Chang1, Sol Kim1, Young Ae Kang, Moo Suk Park, Hojoon Sohn2, and Youngmok Park2Comments to Author 
Author affiliations: Yonsei University College of Medicine, Seoul, South Korea (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Severance Hospital, Seoul (S. Chang, S. Kim, Y.A. Kang, M.S. Park, Y. Park); Seoul National University College of Medicine, Seoul (H. Sohn); Seoul National University Institute of Health Policy and Management, Seoul (H. Sohn)

Main Article

Table 4

Cumulative cost for each category and proportions of out-of-pocket cost in study of medical costs of nontuberculous mycobacterial pulmonary disease, South Korea, 2015–2019*

Period Median cost, US$ (IQR) % Out-of-pocket
Overall follow-up
Total 5,470 (3,613–9,914) 47.4
Medication 1,171 (550–2,509) 29.6
Diagnostic tests 3,093 (2,134–4,597) 49.9
Clinical services
 633 (435–1,749)
 75.7
Prediagnostic
Total 425 (255–1,052) 60.2
Medication 10 (0–77) 30.0
Diagnostic tests 393 (231–766) 56.2
Clinical services
 44 (24–99)
 86.4
Pretreatment
Total 616 (399–1,079) 58.3
Medication 18 (0–74) 33.3
Diagnostic tests 497 (279–864) 60.0
Clinical services
 65 (40–111)
 78.5
Treatment
Total 2,108 (1,660–3,590) 48.8
Medication 814 (512–1,362) 31.0
Diagnostic tests 1,051 (837–1,726) 56.7
Clinical services
 209 (180–303)
 84.7
Post-treatment
Total 451 (138–1,363) 63.6
Medication 7 (0–220) 28.6
Diagnostic tests 295 (94–902) 51.2
Clinical services 89 (42–229) 60.7

*Data are for 87 patients with data for all 4 periods of follow-up.

Main Article

1These first authors contributed equally to this article.

2These authors were co–principal investigators.

Page created: July 30, 2024
Page updated: August 22, 2024
Page reviewed: August 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external